BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8869364)

  • 21. [Pituitary response to GnRH analogue testing in girls with a polycystic ovary syndrome].
    Wikiera B; Wasikowa R
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):13-8. PubMed ID: 16704856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of plasma renin activity in distinguishing patients with polycystic ovary syndrome (PCOS) from oligomenorrheic patients without PCOS.
    Uncu G; Sözer MC; Develioğlu O; Cengiz C
    Gynecol Endocrinol; 2002 Dec; 16(6):447-52. PubMed ID: 12626031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of metformin on gonadotropin-induced ovulation in patients with polycystic ovary syndrome].
    Zhao JZ; Ye BL; Lin JJ; Lin WQ; Chi HH
    Zhonghua Fu Chan Ke Za Zhi; 2003 Sep; 38(9):545-8. PubMed ID: 14680609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An inexpensive method for assessing pituitary response to luteinizing hormone releasing hormones: analysis of serum gonadotropins in pooled samples.
    Tiwary CM
    Horm Metab Res; 1986 Sep; 18(9):616-20. PubMed ID: 3096860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary amenorrhoea associated with polycystic ovarian syndrome.
    Valkov IM; Dokumov SI
    Reproduccion; 1981; 5(2):119-26. PubMed ID: 6790313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gonadotropin-releasing hormone testing in premature thelarche.
    Choubtum L; Mahachoklertwattana P; Sriphrapradang A; Preeyasombat C
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S33-8. PubMed ID: 10730515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
    Peng P; Yang DZ; Zheng CY; Mo YQ; He YM; Zhang QX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of synthetic gonadotropin releasing hormone on the plasma levels of FH and LSH in women with hirsutism and polycystic ovaries].
    Pjević M; Kovac T; Bujas M; Pusac R
    Jugosl Ginekol Perinatol; 1985; 25(3-4):49-52. PubMed ID: 3938829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of hormonal response to the GnRH agonist leuprolide in brothers of women with polycystic ovary syndrome: a pilot study.
    Petermann TS; Cartes A; Maliqueo M; Vantman D; Gutiérrez C; Toloza H; Echiburú B; Recabarren SE
    Hum Reprod; 2004 Dec; 19(12):2742-7. PubMed ID: 15358722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obesity differentially affects serum levels of androstenedione and testosterone in polycystic ovary syndrome.
    Moran C; Renteria JL; Moran S; Herrera J; Gonzalez S; Bermudez JA
    Fertil Steril; 2008 Dec; 90(6):2310-7. PubMed ID: 18163993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome.
    Valkenburg O; Uitterlinden AG; Piersma D; Hofman A; Themmen AP; de Jong FH; Fauser BC; Laven JS
    Hum Reprod; 2009 Aug; 24(8):2014-22. PubMed ID: 19403562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The predication of ovarian response in control ovarian hyperstimulation by the ratio of basal FSH and LH level].
    Liang X; Zhuang G; Zhou C
    Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):819-21. PubMed ID: 11798975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do basal inhibin A and inhibin B levels have value in the diagnosis of polycystic ovary syndrome?
    Torgac M; Kokcu A; Cetinkaya MB; Alper T; Malatyalioglu E
    Gynecol Endocrinol; 2005 Jun; 20(6):322-6. PubMed ID: 16019381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
    Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
    Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum ghrelin, leptin and resistin levels in adolescent girls with polycystic ovary syndrome.
    Bideci A; Camurdan MO; Yeşilkaya E; Demirel F; Cinaz P
    J Obstet Gynaecol Res; 2008 Aug; 34(4):578-84. PubMed ID: 18937712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of atropine on hypophyseal gonadotropins in the basal condition and under GnRH stimulation].
    Bizzarro A; Iannucci F; Verdoliva A; Soricelli A; Guarino G; De Matteo A; L'Abbate V
    Boll Soc Ital Biol Sper; 1980 Jun; 56(12):1275-80. PubMed ID: 6779831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reproducibility of luteinizing hormone hypersecretion in different phases of the menstrual cycle in polycystic ovary syndrome.
    Iwasa T; Matsuzaki T; Murakami M; Shimizu F; Kuwahara A; Yasui T; Irahara M
    J Obstet Gynaecol Res; 2009 Jun; 35(3):514-9. PubMed ID: 19527392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The applicability of LH and FSH determination to the diagnosis of Stein-Leventhal syndrome].
    Zenísek L; Talas M; Stehlíková J; Fingerová H; Dusková M
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():146-8. PubMed ID: 6211041
    [No Abstract]   [Full Text] [Related]  

  • 40. Ovarian pregnancy in polycystic ovary syndrome: a case report.
    Cataldo NA
    Int J Fertil; 1992; 37(3):144-5. PubMed ID: 1355760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.